Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Conditions: Breast Cancer; Metastatic Breast Cancer; Hormone Receptor-positive Breast Cancer; HER2-negative Breast Cancer Interventions: Drug: Fulvestrant; Drug: Anastrozole; Drug: Abemaciclib Sponsor: University of California, Irvine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials